rs17119344

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005379.4(MYO1A):​c.2987C>T​(p.Thr996Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0855 in 1,613,994 control chromosomes in the GnomAD database, including 6,213 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.090 ( 646 hom., cov: 31)
Exomes 𝑓: 0.085 ( 5567 hom. )

Consequence

MYO1A
NM_005379.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.23

Publications

24 publications found
Variant links:
Genes affected
MYO1A (HGNC:7595): (myosin IA) This gene encodes a member of the myosin superfamily. The protein represents an unconventional myosin; it should not be confused with the conventional skeletal muscle myosin-1 (MYH1). Unconventional myosins contain the basic domains characteristic of conventional myosins and are further distinguished from class members by their tail domains. They function as actin-based molecular motors. Mutations in this gene have been associated with autosomal dominant deafness. Alternatively spliced variants have been found for this gene. [provided by RefSeq, Dec 2011]
MYO1A Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0014393628).
BP6
Variant 12-57029150-G-A is Benign according to our data. Variant chr12-57029150-G-A is described in ClinVar as Benign. ClinVar VariationId is 45311.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.172 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO1ANM_005379.4 linkc.2987C>T p.Thr996Ile missense_variant Exon 27 of 28 ENST00000300119.8 NP_005370.1
MYO1ANM_001256041.2 linkc.2987C>T p.Thr996Ile missense_variant Exon 28 of 29 NP_001242970.1
MYO1AXM_047428876.1 linkc.2987C>T p.Thr996Ile missense_variant Exon 28 of 29 XP_047284832.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO1AENST00000300119.8 linkc.2987C>T p.Thr996Ile missense_variant Exon 27 of 28 1 NM_005379.4 ENSP00000300119.3

Frequencies

GnomAD3 genomes
AF:
0.0897
AC:
13632
AN:
152018
Hom.:
647
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0792
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.118
Gnomad ASJ
AF:
0.0746
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.105
Gnomad FIN
AF:
0.104
Gnomad MID
AF:
0.0570
Gnomad NFE
AF:
0.0810
Gnomad OTH
AF:
0.0820
GnomAD2 exomes
AF:
0.0952
AC:
23903
AN:
251188
AF XY:
0.0950
show subpopulations
Gnomad AFR exome
AF:
0.0804
Gnomad AMR exome
AF:
0.0881
Gnomad ASJ exome
AF:
0.0763
Gnomad EAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.103
Gnomad NFE exome
AF:
0.0841
Gnomad OTH exome
AF:
0.0883
GnomAD4 exome
AF:
0.0851
AC:
124358
AN:
1461858
Hom.:
5567
Cov.:
33
AF XY:
0.0850
AC XY:
61804
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.0804
AC:
2692
AN:
33480
American (AMR)
AF:
0.0904
AC:
4041
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0742
AC:
1939
AN:
26134
East Asian (EAS)
AF:
0.139
AC:
5528
AN:
39700
South Asian (SAS)
AF:
0.100
AC:
8650
AN:
86258
European-Finnish (FIN)
AF:
0.102
AC:
5458
AN:
53416
Middle Eastern (MID)
AF:
0.0884
AC:
510
AN:
5768
European-Non Finnish (NFE)
AF:
0.0813
AC:
90402
AN:
1111984
Other (OTH)
AF:
0.0851
AC:
5138
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
7543
15086
22629
30172
37715
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3412
6824
10236
13648
17060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0896
AC:
13637
AN:
152136
Hom.:
646
Cov.:
31
AF XY:
0.0924
AC XY:
6869
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.0791
AC:
3283
AN:
41528
American (AMR)
AF:
0.118
AC:
1803
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0746
AC:
259
AN:
3470
East Asian (EAS)
AF:
0.181
AC:
937
AN:
5166
South Asian (SAS)
AF:
0.105
AC:
507
AN:
4814
European-Finnish (FIN)
AF:
0.104
AC:
1098
AN:
10570
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0810
AC:
5508
AN:
67992
Other (OTH)
AF:
0.0835
AC:
176
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
594
1189
1783
2378
2972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0851
Hom.:
1866
Bravo
AF:
0.0891
TwinsUK
AF:
0.0771
AC:
286
ALSPAC
AF:
0.0786
AC:
303
ESP6500AA
AF:
0.0856
AC:
377
ESP6500EA
AF:
0.0852
AC:
733
ExAC
AF:
0.0944
AC:
11462
Asia WGS
AF:
0.133
AC:
460
AN:
3478
EpiCase
AF:
0.0773
EpiControl
AF:
0.0722

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Thr996Ile in Exon 27 of MYO1A: This variant is not expected to have clinical sig nificance because it has been identified in 8.6% (605/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http ://evs.gs.washington.edu/EVS; dbSNP rs17119344). -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
18
DANN
Benign
0.89
DEOGEN2
Benign
0.067
T;T
Eigen
Benign
-0.71
Eigen_PC
Benign
-0.66
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.10
.;T
MetaRNN
Benign
0.0014
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
1.2
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.029
Sift
Benign
0.20
T;T
Sift4G
Benign
0.20
T;T
Polyphen
0.029
B;B
Vest4
0.076
MPC
0.088
ClinPred
0.0044
T
GERP RS
4.1
PromoterAI
-0.026
Neutral
Varity_R
0.075
gMVP
0.10
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17119344; hg19: chr12-57422934; COSMIC: COSV55657629; COSMIC: COSV55657629; API